Court rules in DSM, Lallemand patent infringement case

May 17, 2018

BY Erin Krueger

On May 16, Royal DSM announced it has received unanimous jury verdict in a federal court in Wisconsin concluding that glycerol-reducing yeast products sold by Lallemand infringe on DSM’s U.S. Patent 8,795,998. In response, Lallemand indicated it will not comment while the legal dispute is ongoing.

"We are happy with the outcome of the case. Our focus is to bring customers the latest in yeast technology allowing them to deliver the best fermentation results," said Atul Thakrar, president of DSM Bio-based Products & Services. "Continual development and protecting this intellectual property is a key component of our strategy that supports our significant biofuel investments. We are committed to deliver differentiating yeast and enzyme technologies that enable biofuel plant owners to optimize their processes and maximize their yields and profits in a sustainable way."

In court, DSM alleged that Lallemand’s glycerol-reducing yeast products, including Transferm Yield-plus and YP3 used in the production of ethanol, infringe upon DSM’s U.S. 8,795,998 patent. After seven days of trial, DSM said the jury concluded that the DSM patent is valid and is being infringed by Lallemand’s glycerol-reducing yeast products.

Advertisement

Advertisement

"Lallemand Biofuels & Distilled Spirits prefers not to comment while this legal dispute is ongoing,” said Angus Ballard, president and general manager of Lallemand. “We would like to thank our customers for their continued trust and support while we continue the legal process to ultimately resolve this dispute between Lallemand and DSM."

 

Advertisement

Advertisement

Related Stories

CoBank’s latest quarterly research report, released July 10, highlights current uncertainty around the implementation of three biofuel policies, RFS RVOs, small refinery exemptions (SREs) and the 45Z clean fuels production tax credit.

Read More

The U.S. Energy Information Administration maintained its forecast for 2025 and 2026 biodiesel, renewable diesel and sustainable aviation fuel (SAF) production in its latest Short-Term Energy Outlook, released July 8.

Read More

XCF Global Inc. on July 10 shared its strategic plan to invest close to $1 billion in developing a network of SAF production facilities, expanding its U.S. footprint, and advancing its international growth strategy.

Read More

U.S. fuel ethanol capacity fell slightly in April, while biodiesel and renewable diesel capacity held steady, according to data released by the U.S. EIA on June 30. Feedstock consumption was down when compared to the previous month.

Read More

XCF Global Inc. on July 8 provided a production update on its flagship New Rise Reno facility, underscoring that the plant has successfully produced SAF, renewable diesel, and renewable naphtha during its initial ramp-up.

Read More

Upcoming Events

Sign up for our e-newsletter!

Advertisement

Advertisement